Skip to main content
Erschienen in: Current Treatment Options in Neurology 12/2018

01.12.2018 | Neurologic Ophthalmology and Otology (R Shin and D Gold, Section Editors)

Treatment of Persistent Postural-Perceptual Dizziness (PPPD) and Related Disorders

verfasst von: Stoyan Popkirov, MD, Jon Stone, PhD, Dagny Holle-Lee, MD

Erschienen in: Current Treatment Options in Neurology | Ausgabe 12/2018

Einloggen, um Zugang zu erhalten

Abstract

Purpose of review

Persistent postural-perceptual dizziness (PPPD) is a newly defined disorder of functional dizziness that in the International Classification of Diseases in its 11th revision (ICD-11) supersedes phobic postural vertigo and chronic subjective dizziness. Despite efforts to unify the diagnosis of functional (somatoform) dizziness, patients will present with a variety of triggers, perpetuating factors, and comorbidities, requiring individualized treatment. This article will review different treatment strategies for this common functional neurological disorder and provide practical recommendations for tailored therapy.

Recent findings

An emerging understanding of the underlying pathophysiology that considers vestibular, postural, cognitive, and emotional aspects can enable patients to profit from vestibular rehabilitation, as well as cognitive-behavioral therapy (CBT). Crucially, approaches from CBT should inform and augment physiotherapeutic techniques, and, on the other hand, vestibular exercises or relaxation techniques can be integrated into CBT programs. Antidepressant medication might further facilitate rehabilitation, though the mechanisms are yet to be elucidated, and the level of evidence is low.

Summary

In PPPD and related disorders, vestibular rehabilitation combined with CBT, and possibly supported by medication, can help patients escape a cycle of maladaptive balance control, recalibrate vestibular systems, and regain independence in everyday life.
Literatur
1.
Zurück zum Zitat •• Staab JP, Eckhardt-Henn A, Horii A, Jacob R, Strupp M, Brandt T, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society. J Vestib Res. 2017;27(4):191–208 Consensus document defining the diagnostic entity of PPPD.CrossRef •• Staab JP, Eckhardt-Henn A, Horii A, Jacob R, Strupp M, Brandt T, et al. Diagnostic criteria for persistent postural-perceptual dizziness (PPPD): consensus document of the committee for the Classification of Vestibular Disorders of the Bárány Society. J Vestib Res. 2017;27(4):191–208 Consensus document defining the diagnostic entity of PPPD.CrossRef
2.
Zurück zum Zitat • Popkirov S, Staab JP, Stone J. Persistent postural-perceptual dizziness (PPPD): a common, characteristic and treatable cause of chronic dizziness. Pract Neurol. 2018;18(1):5–13 Recent overview of PPPD from a practical standpoint.CrossRef • Popkirov S, Staab JP, Stone J. Persistent postural-perceptual dizziness (PPPD): a common, characteristic and treatable cause of chronic dizziness. Pract Neurol. 2018;18(1):5–13 Recent overview of PPPD from a practical standpoint.CrossRef
3.
Zurück zum Zitat Dieterich M, Staab JP. Functional dizziness: from phobic postural vertigo and chronic subjective dizziness to persistent postural-perceptual dizziness. Curr Opin Neurol. 2017 Feb;30(1):107–13.CrossRef Dieterich M, Staab JP. Functional dizziness: from phobic postural vertigo and chronic subjective dizziness to persistent postural-perceptual dizziness. Curr Opin Neurol. 2017 Feb;30(1):107–13.CrossRef
4.
Zurück zum Zitat Dieterich M, Staab JP, Brandt T. Functional (psychogenic) dizziness. Handb Clin Neurol. 2016;139:447–68.CrossRef Dieterich M, Staab JP, Brandt T. Functional (psychogenic) dizziness. Handb Clin Neurol. 2016;139:447–68.CrossRef
5.
Zurück zum Zitat • Stone J, Carson A, Hallett M. Explanation as treatment for functional neurologic disorders. Handb Clin Neurol. 2016;139:543–53 Article providing advice on the difficult task of explaining functional disorders such as PPPD.CrossRef • Stone J, Carson A, Hallett M. Explanation as treatment for functional neurologic disorders. Handb Clin Neurol. 2016;139:543–53 Article providing advice on the difficult task of explaining functional disorders such as PPPD.CrossRef
6.
Zurück zum Zitat Stone J. Functional neurological disorders: the neurological assessment as treatment. Pract Neurol. 2016;16(1):7–17.CrossRef Stone J. Functional neurological disorders: the neurological assessment as treatment. Pract Neurol. 2016;16(1):7–17.CrossRef
7.
Zurück zum Zitat Obermann M, Bock E, Sabev N, Lehmann N, Weber R, Gerwig M, et al. Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care: the Dizziness and Vertigo Registry (DiVeR) Study. J Neurol. 2015 Sep;262(9):2083–91.CrossRef Obermann M, Bock E, Sabev N, Lehmann N, Weber R, Gerwig M, et al. Long-term outcome of vertigo and dizziness associated disorders following treatment in specialized tertiary care: the Dizziness and Vertigo Registry (DiVeR) Study. J Neurol. 2015 Sep;262(9):2083–91.CrossRef
8.
Zurück zum Zitat Stone J, Edwards M. Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology. 2012;79(3):282–4.CrossRef Stone J, Edwards M. Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology. 2012;79(3):282–4.CrossRef
10.
Zurück zum Zitat • Staab JP. Behavioral aspects of vestibular rehabilitation. NeuroRehabilitation. 2011;29(2):179Y183. Excellent review that considers the integration of vestibular rehabilitation exercises with cognitive-behavioral therapy. • Staab JP. Behavioral aspects of vestibular rehabilitation. NeuroRehabilitation. 2011;29(2):179Y183. Excellent review that considers the integration of vestibular rehabilitation exercises with cognitive-behavioral therapy.
11.
Zurück zum Zitat Pavlou M, Lingeswaran A, Davies RA, Gresty MA, Bronstein AM. Simulator based rehabilitation in refractory dizziness. J Neurol. 2004;251(8):983–95.CrossRef Pavlou M, Lingeswaran A, Davies RA, Gresty MA, Bronstein AM. Simulator based rehabilitation in refractory dizziness. J Neurol. 2004;251(8):983–95.CrossRef
12.
Zurück zum Zitat Jacob RG, Whitney SL, Detweiler-Shostak G, Furman JM. Vestibular rehabilitation for patients with agoraphobia and vestibular dysfunction: a pilot study. J Anxiety Disord. 2001;15(1–2):131–46.CrossRef Jacob RG, Whitney SL, Detweiler-Shostak G, Furman JM. Vestibular rehabilitation for patients with agoraphobia and vestibular dysfunction: a pilot study. J Anxiety Disord. 2001;15(1–2):131–46.CrossRef
13.
Zurück zum Zitat Thompson KJ, Goetting JC, Staab JP, Shepard NT. Retrospective review and telephone follow-up to evaluate a physical therapy protocol for treating persistent postural-perceptual dizziness: a pilot study. J Vestib Res. 2015;25(2):97–103 quiz 103–4.PubMed Thompson KJ, Goetting JC, Staab JP, Shepard NT. Retrospective review and telephone follow-up to evaluate a physical therapy protocol for treating persistent postural-perceptual dizziness: a pilot study. J Vestib Res. 2015;25(2):97–103 quiz 103–4.PubMed
17.
Zurück zum Zitat Nielsen G, Stone J, Matthews A, Brown M, Sparkes C, Farmer R, et al. Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2015;86(10):1113–9.CrossRef Nielsen G, Stone J, Matthews A, Brown M, Sparkes C, Farmer R, et al. Physiotherapy for functional motor disorders: a consensus recommendation. J Neurol Neurosurg Psychiatry. 2015;86(10):1113–9.CrossRef
18.
Zurück zum Zitat Morisod B, Mermod M, Maire R. Posturographic pattern of patients with chronic subjective dizziness before and after vestibular rehabilitation. J Vestib Res. 2018;27(5–6):305–11.CrossRef Morisod B, Mermod M, Maire R. Posturographic pattern of patients with chronic subjective dizziness before and after vestibular rehabilitation. J Vestib Res. 2018;27(5–6):305–11.CrossRef
19.
Zurück zum Zitat Whalley MG, Cane DA. A cognitive-behavioral model of persistent postural-perceptual dizziness. Cogn Behav Pract. 2016;24:72–89.CrossRef Whalley MG, Cane DA. A cognitive-behavioral model of persistent postural-perceptual dizziness. Cogn Behav Pract. 2016;24:72–89.CrossRef
20.
Zurück zum Zitat Brandt T, Huppert D, Dieterich M. Phobic postural vertigo: a first follow-up. J Neurol. 1994;241(4):191–5.CrossRef Brandt T, Huppert D, Dieterich M. Phobic postural vertigo: a first follow-up. J Neurol. 1994;241(4):191–5.CrossRef
21.
Zurück zum Zitat Huppert D, Strupp M, Rettinger N, Hecht J, Brandt T. Phobic postural vertigo—a long-term follow-up (5 to 15 years) of 106 patients. J Neurol. 2005;252(5):564–9.CrossRef Huppert D, Strupp M, Rettinger N, Hecht J, Brandt T. Phobic postural vertigo—a long-term follow-up (5 to 15 years) of 106 patients. J Neurol. 2005;252(5):564–9.CrossRef
22.
Zurück zum Zitat Holmberg J, Karlberg M, Harlacher U, Rivano-Fischer M, Magnusson M. Treatment of phobic postural vertigo. A controlled study of cognitive-behavioral therapy and self-controlled desensitization. J Neurol. 2006;253(4):500–6.CrossRef Holmberg J, Karlberg M, Harlacher U, Rivano-Fischer M, Magnusson M. Treatment of phobic postural vertigo. A controlled study of cognitive-behavioral therapy and self-controlled desensitization. J Neurol. 2006;253(4):500–6.CrossRef
23.
Zurück zum Zitat • Edelman S, Mahoney AE, Cremer PD. Cognitive behavior therapy for chronic subjective dizziness: a randomized, controlled trial. Am J Otolaryngol. 2012;33(4):395–401 Trial demonstrating lasting effects of 3 CBT sessions on CSD symptoms.CrossRef • Edelman S, Mahoney AE, Cremer PD. Cognitive behavior therapy for chronic subjective dizziness: a randomized, controlled trial. Am J Otolaryngol. 2012;33(4):395–401 Trial demonstrating lasting effects of 3 CBT sessions on CSD symptoms.CrossRef
24.
Zurück zum Zitat Best C, Tschan R, Stieber N, Beutel ME, Eckhardt-Henn A, Dieterich M. STEADFAST: psychotherapeutic intervention improves postural strategy of somatoform vertigo and dizziness. Behav Neurol. 2015;2015:456850.CrossRef Best C, Tschan R, Stieber N, Beutel ME, Eckhardt-Henn A, Dieterich M. STEADFAST: psychotherapeutic intervention improves postural strategy of somatoform vertigo and dizziness. Behav Neurol. 2015;2015:456850.CrossRef
25.
Zurück zum Zitat Yu YC, Xue H, Zhang YX, Zhou J. Cognitive behavior therapy as augmentation for sertraline in treating patients with persistent postural-perceptual dizziness. Biomed Res Int. 2018;2018:8518631.PubMedPubMedCentral Yu YC, Xue H, Zhang YX, Zhou J. Cognitive behavior therapy as augmentation for sertraline in treating patients with persistent postural-perceptual dizziness. Biomed Res Int. 2018;2018:8518631.PubMedPubMedCentral
26.
Zurück zum Zitat Holmberg J, Karlberg M, Harlacher U, Magnusson M. One-year follow-up of cognitive behavioral therapy for phobic postural vertigo. J Neurol. 2007;254:1189–92.CrossRef Holmberg J, Karlberg M, Harlacher U, Magnusson M. One-year follow-up of cognitive behavioral therapy for phobic postural vertigo. J Neurol. 2007;254:1189–92.CrossRef
27.
Zurück zum Zitat Mahoney AEJ, Edelman S, Cremer PD. Cognitive behavior therapy for chronic subjective dizziness: longerterm gains and predictors of disability. Am J Otolaryngol. 2013;34:115–20.CrossRef Mahoney AEJ, Edelman S, Cremer PD. Cognitive behavior therapy for chronic subjective dizziness: longerterm gains and predictors of disability. Am J Otolaryngol. 2013;34:115–20.CrossRef
28.
Zurück zum Zitat Tschan R, Eckhardt-Henn A, Scheurich V, Best C, Dieterich M, Beutel M. [__Steadfast—effectiveness of a cognitive-behavioral self-management program for patients with somatoform vertigo and dizziness]. Psychother Psychosom Med Psychol. 2012;62(3–4):111–9.PubMed Tschan R, Eckhardt-Henn A, Scheurich V, Best C, Dieterich M, Beutel M. [__Steadfast—effectiveness of a cognitive-behavioral self-management program for patients with somatoform vertigo and dizziness]. Psychother Psychosom Med Psychol. 2012;62(3–4):111–9.PubMed
29.
Zurück zum Zitat Lahmann C, Henningsen P, Dieterich M, Radziej K, Schmid G. Tailored care for somatoform vertigo/dizziness: study protocol for a randomised controlled trial evaluating integrative group psychotherapy. J Neurol. 2015;262(8):1867–75.CrossRef Lahmann C, Henningsen P, Dieterich M, Radziej K, Schmid G. Tailored care for somatoform vertigo/dizziness: study protocol for a randomised controlled trial evaluating integrative group psychotherapy. J Neurol. 2015;262(8):1867–75.CrossRef
30.
Zurück zum Zitat • Staab JP. Chronic subjective dizziness. Continuum (Minneap Minn). 2012;18(5):1118–41 Insightful review of CSD treatment that includes dosing regimes for SSRI/SNRI.PubMed • Staab JP. Chronic subjective dizziness. Continuum (Minneap Minn). 2012;18(5):1118–41 Insightful review of CSD treatment that includes dosing regimes for SSRI/SNRI.PubMed
31.
Zurück zum Zitat Staab JP, Ruckenstein MJ, Solomon D, Shepard NT. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch Otolaryngol Head Neck Surg. 2002;128(5):554–60.CrossRef Staab JP, Ruckenstein MJ, Solomon D, Shepard NT. Serotonin reuptake inhibitors for dizziness with psychiatric symptoms. Arch Otolaryngol Head Neck Surg. 2002;128(5):554–60.CrossRef
32.
Zurück zum Zitat Staab JP, Ruckenstein MJ, Amsterdam JD. A prospective trial of sertraline for chronic subjective dizziness. Laryngoscope. 2004;114(9):1637–41.CrossRef Staab JP, Ruckenstein MJ, Amsterdam JD. A prospective trial of sertraline for chronic subjective dizziness. Laryngoscope. 2004;114(9):1637–41.CrossRef
33.
Zurück zum Zitat Horii A, Mitani K, Kitahara T, Uno A, Takeda N, Kubo T. Paroxetine, a selective serotonin reuptake inhibitor, reduces depressive symptoms and subjective handicaps in patients with dizziness. Otol Neurotol. 2004;25(4):536–43.CrossRef Horii A, Mitani K, Kitahara T, Uno A, Takeda N, Kubo T. Paroxetine, a selective serotonin reuptake inhibitor, reduces depressive symptoms and subjective handicaps in patients with dizziness. Otol Neurotol. 2004;25(4):536–43.CrossRef
34.
Zurück zum Zitat • Staab JP, Ruckenstein MJ. Chronic dizziness and anxiety: effect of course of illness on treatment outcome. Arch Otolaryngol Head Neck Surg. 2005;131(8):675–9. Larger open-label trial of SSRI for chronic subjective dizziness.CrossRef • Staab JP, Ruckenstein MJ. Chronic dizziness and anxiety: effect of course of illness on treatment outcome. Arch Otolaryngol Head Neck Surg. 2005;131(8):675–9. Larger open-label trial of SSRI for chronic subjective dizziness.CrossRef
35.
Zurück zum Zitat Horii A, Uno A, Kitahara T, Mitani K, Masumura C, Kizawa K, et al. Effects of fluvoxamine on anxiety, depression, and subjective handicaps of chronic dizziness patients with or without neuro-otologic diseases. J Vestib Res. 2007;17(1):1–8.PubMed Horii A, Uno A, Kitahara T, Mitani K, Masumura C, Kizawa K, et al. Effects of fluvoxamine on anxiety, depression, and subjective handicaps of chronic dizziness patients with or without neuro-otologic diseases. J Vestib Res. 2007;17(1):1–8.PubMed
37.
Zurück zum Zitat Horii A, Imai T, Kitahara T, Uno A, Morita Y, Takahashi K, et al. Psychiatric comorbidities and use of milnacipran in patients with chronic dizziness. J Vestib Res. 2016;26(3):335–40.CrossRef Horii A, Imai T, Kitahara T, Uno A, Morita Y, Takahashi K, et al. Psychiatric comorbidities and use of milnacipran in patients with chronic dizziness. J Vestib Res. 2016;26(3):335–40.CrossRef
38.
Zurück zum Zitat Rascol O, Hain TC, Brefel C, Benazet M, Clanet M, Montastruc JL. Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs. 1995;50(5):777–91.CrossRef Rascol O, Hain TC, Brefel C, Benazet M, Clanet M, Montastruc JL. Antivertigo medications and drug-induced vertigo. A pharmacological review. Drugs. 1995;50(5):777–91.CrossRef
39.
Zurück zum Zitat Holle D, Schulte-Steinberg B, Wurthmann S, Naegel S, Ayzenberg I, Diener HC, et al. Persistent postural-perceptual dizziness: a matter of higher, central dysfunction? PLoS One. 2015;10(11):e0142468.CrossRef Holle D, Schulte-Steinberg B, Wurthmann S, Naegel S, Ayzenberg I, Diener HC, et al. Persistent postural-perceptual dizziness: a matter of higher, central dysfunction? PLoS One. 2015;10(11):e0142468.CrossRef
40.
Zurück zum Zitat Wurthmann S, Naegel S, Schulte Steinberg B, Theysohn N, Diener HC, Kleinschnitz C, et al. Cerebral gray matter changes in persistent postural perceptual dizziness. J Psychosom Res. 2017;103:95–101.CrossRef Wurthmann S, Naegel S, Schulte Steinberg B, Theysohn N, Diener HC, Kleinschnitz C, et al. Cerebral gray matter changes in persistent postural perceptual dizziness. J Psychosom Res. 2017;103:95–101.CrossRef
41.
Metadaten
Titel
Treatment of Persistent Postural-Perceptual Dizziness (PPPD) and Related Disorders
verfasst von
Stoyan Popkirov, MD
Jon Stone, PhD
Dagny Holle-Lee, MD
Publikationsdatum
01.12.2018
Verlag
Springer US
Erschienen in
Current Treatment Options in Neurology / Ausgabe 12/2018
Print ISSN: 1092-8480
Elektronische ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-018-0535-0

Weitere Artikel der Ausgabe 12/2018

Current Treatment Options in Neurology 12/2018 Zur Ausgabe

Pediatric Neurology (A Yeshokumar, Section Editor)

Neurotoxicity of Anesthesia in Children: Prevention and Treatment

Multiple Sclerosis and Related Disorders (J Graves, Section Editor)

Cognitive Deficits in Multiple Sclerosis: Recent Advances in Treatment and Neurorehabilitation

Movement Disorders (A Videnovic, Section Editor)

Gastrointestinal Dysfunction in Parkinson’s Disease

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Demenzkranke durch Antipsychotika vielfach gefährdet

Demenz Nachrichten

Der Einsatz von Antipsychotika gegen psychische und Verhaltenssymptome in Zusammenhang mit Demenzerkrankungen erfordert eine sorgfältige Nutzen-Risiken-Abwägung. Neuen Erkenntnissen zufolge sind auf der Risikoseite weitere schwerwiegende Ereignisse zu berücksichtigen.

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.